1in2

From Proteopedia

(Difference between revisions)
Jump to: navigation, search
Current revision (08:06, 11 January 2023) (edit) (undo)
 
(9 intermediate revisions not shown.)
Line 1: Line 1:
-
[[Image:1in2.jpg|left|200px]]
 
-
{{Structure
+
==Peptide Antagonist of IGFBP1, (i,i+7) Covalently Restrained Analog==
-
|PDB= 1in2 |SIZE=350|CAPTION= <scene name='initialview01'>1in2</scene>
+
<StructureSection load='1in2' size='340' side='right'caption='[[1in2]]' scene=''>
-
|SITE=
+
== Structural highlights ==
-
|LIGAND= <scene name='pdbligand=ACE:ACETYL+GROUP'>ACE</scene>, <scene name='pdbligand=LNK:PENTANE'>LNK</scene>, <scene name='pdbligand=NH2:AMINO+GROUP'>NH2</scene>
+
<table><tr><td colspan='2'>[[1in2]] is a 1 chain structure. Full experimental information is available from [http://oca.weizmann.ac.il/oca-bin/ocashort?id=1IN2 OCA]. For a <b>guided tour on the structure components</b> use [https://proteopedia.org/fgij/fg.htm?mol=1IN2 FirstGlance]. <br>
-
|ACTIVITY=
+
</td></tr><tr id='ligand'><td class="sblockLbl"><b>[[Ligand|Ligands:]]</b></td><td class="sblockDat" id="ligandDat"><scene name='pdbligand=ACE:ACETYL+GROUP'>ACE</scene>, <scene name='pdbligand=LNK:PENTANE'>LNK</scene>, <scene name='pdbligand=NH2:AMINO+GROUP'>NH2</scene></td></tr>
-
|GENE=
+
<tr id='resources'><td class="sblockLbl"><b>Resources:</b></td><td class="sblockDat"><span class='plainlinks'>[https://proteopedia.org/fgij/fg.htm?mol=1in2 FirstGlance], [http://oca.weizmann.ac.il/oca-bin/ocaids?id=1in2 OCA], [https://pdbe.org/1in2 PDBe], [https://www.rcsb.org/pdb/explore.do?structureId=1in2 RCSB], [https://www.ebi.ac.uk/pdbsum/1in2 PDBsum], [https://prosat.h-its.org/prosat/prosatexe?pdbcode=1in2 ProSAT]</span></td></tr>
-
|DOMAIN=
+
</table>
-
|RELATEDENTRY=[[1imw|1imw]], [[1in3|1in3]], [[1gje|1gje]], [[1gjf|1gjf]], [[1gjg|1gjg]]
+
<div style="background-color:#fffaf0;">
-
|RESOURCES=<span class='plainlinks'>[http://oca.weizmann.ac.il/oca-docs/fgij/fg.htm?mol=1in2 FirstGlance], [http://oca.weizmann.ac.il/oca-bin/ocaids?id=1in2 OCA], [http://www.ebi.ac.uk/pdbsum/1in2 PDBsum], [http://www.rcsb.org/pdb/explore.do?structureId=1in2 RCSB]</span>
+
== Publication Abstract from PubMed ==
-
}}
+
-
 
+
-
'''Peptide Antagonist of IGFBP1, (i,i+7) Covalently Restrained Analog'''
+
-
 
+
-
 
+
-
==Overview==
+
Highly structured, peptide antagonists of the interaction between insulin-like growth factor 1 (IGF-I) and IGF binding protein 1 (IGFBP-1) have recently been discovered by phage display of naive peptide libraries [Lowman, H. B., et al. (1998) Biochemistry 37, 8870--8878]. We now report a detailed analysis of the features of this turn-helix peptide motif that are necessary for IGFBP-1 binding and structural integrity. Further rounds of phage randomization indicate the importance of residues contributing to a hydrophobic patch on one face of the helix. Alanine-scanning substitutions confirm that the hydrophobic residues are necessary for binding. However, structural analysis by NMR spectroscopy indicates that some of these analogues are less well folded. Structured, high-affinity analogues that lack the disulfide bond were prepared by introducing a covalent constraint between side chains at positions i and i + 7 or i + 8 within the helix. Analogues based on this scaffold demonstrate that a helical conformation is present in the bound state, and that hydrophobic side chains in this helix, and residues immediately preceding it, interact with IGFBP-1. By comparison of alanine scanning data for IGF-I and the turn-helix peptide, we propose a model for common surface features of these molecules that recognize IGFBP-1.
Highly structured, peptide antagonists of the interaction between insulin-like growth factor 1 (IGF-I) and IGF binding protein 1 (IGFBP-1) have recently been discovered by phage display of naive peptide libraries [Lowman, H. B., et al. (1998) Biochemistry 37, 8870--8878]. We now report a detailed analysis of the features of this turn-helix peptide motif that are necessary for IGFBP-1 binding and structural integrity. Further rounds of phage randomization indicate the importance of residues contributing to a hydrophobic patch on one face of the helix. Alanine-scanning substitutions confirm that the hydrophobic residues are necessary for binding. However, structural analysis by NMR spectroscopy indicates that some of these analogues are less well folded. Structured, high-affinity analogues that lack the disulfide bond were prepared by introducing a covalent constraint between side chains at positions i and i + 7 or i + 8 within the helix. Analogues based on this scaffold demonstrate that a helical conformation is present in the bound state, and that hydrophobic side chains in this helix, and residues immediately preceding it, interact with IGFBP-1. By comparison of alanine scanning data for IGF-I and the turn-helix peptide, we propose a model for common surface features of these molecules that recognize IGFBP-1.
-
==About this Structure==
+
Structure-function analysis of a phage display-derived peptide that binds to insulin-like growth factor binding protein 1.,Skelton NJ, Chen YM, Dubree N, Quan C, Jackson DY, Cochran A, Zobel K, Deshayes K, Baca M, Pisabarro MT, Lowman HB Biochemistry. 2001 Jul 24;40(29):8487-98. PMID:11456486<ref>PMID:11456486</ref>
-
1IN2 is a [[Protein complex]] structure of sequences from [http://en.wikipedia.org/wiki/ ]. Full crystallographic information is available from [http://oca.weizmann.ac.il/oca-bin/ocashort?id=1IN2 OCA].
+
-
 
+
-
==Reference==
+
-
Structure-function analysis of a phage display-derived peptide that binds to insulin-like growth factor binding protein 1., Skelton NJ, Chen YM, Dubree N, Quan C, Jackson DY, Cochran A, Zobel K, Deshayes K, Baca M, Pisabarro MT, Lowman HB, Biochemistry. 2001 Jul 24;40(29):8487-98. PMID:[http://www.ncbi.nlm.nih.gov/pubmed/11456486 11456486]
+
-
[[Category: Protein complex]]
+
-
[[Category: Baca, M.]]
+
-
[[Category: Chen, Y M.]]
+
-
[[Category: Cochran, A G.]]
+
-
[[Category: Deshayes, K.]]
+
-
[[Category: Dubree, N.]]
+
-
[[Category: Jackson, D Y.]]
+
-
[[Category: Lowman, H B.]]
+
-
[[Category: Pisabarro, M T.]]
+
-
[[Category: Quan, C.]]
+
-
[[Category: Skelton, N J.]]
+
-
[[Category: Zobel, K.]]
+
-
[[Category: covalently constrained helix]]
+
-
''Page seeded by [http://oca.weizmann.ac.il/oca OCA ] on Sun Mar 30 21:21:58 2008''
+
From MEDLINE&reg;/PubMed&reg;, a database of the U.S. National Library of Medicine.<br>
 +
</div>
 +
<div class="pdbe-citations 1in2" style="background-color:#fffaf0;"></div>
 +
== References ==
 +
<references/>
 +
__TOC__
 +
</StructureSection>
 +
[[Category: Large Structures]]
 +
[[Category: Baca M]]
 +
[[Category: Chen YM]]
 +
[[Category: Cochran AG]]
 +
[[Category: Deshayes K]]
 +
[[Category: Dubree N]]
 +
[[Category: Jackson DY]]
 +
[[Category: Lowman HB]]
 +
[[Category: Pisabarro MT]]
 +
[[Category: Quan C]]
 +
[[Category: Skelton NJ]]
 +
[[Category: Zobel K]]

Current revision

Peptide Antagonist of IGFBP1, (i,i+7) Covalently Restrained Analog

PDB ID 1in2

Drag the structure with the mouse to rotate

Proteopedia Page Contributors and Editors (what is this?)

OCA

Personal tools